Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Science Translational Medicine, 2021
Reyes M., Filbin M., Bhattacharyya R., Sonny A., Mehta A., Billman K., Kays K., Pinilla-Vera M., Benson M., Cosimi L., Hung D., Levy B., Villani A., Sade-Feldman M., Baron R., Goldberg M., Blainey P., Hacohen N.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Infectious Diseases | Pathophysiology | Plasma |  Olink Explore 3072/384 |
Abstract
Cytokines in plasma from sepsis or severe COVID-19 patients induce production of suppressive myeloid cells from hematopoietic progenitors in vitro.